Latest AMBOSS News & Updates

AMBOSS AI Mode ranks first in Stanford/Harvard study

Forbes highlights the NOHARM study where AMBOSS AI Mode Clinical Care (LiSA 1.0) outperforms others due to its curated medical knowledge base. AMBOSS prioritizes patient safety and responsible AI.

AMBOSS introduces AI Mode Learning

It serves as an AI study copilot integrated into the platform, providing trusted explanations, targeted practice, and progress tracking for medical learners.

AMBOSS AI Mode ranks #1 in NOHARM study

It topped clinical safety among 31 AI systems in Stanford-Harvard benchmark using 100 real cases across 10 specialties. Performance prioritized patient safety and context-aware reasoning.

AMBOSS announces LiSA ranks #1 in clinical AI benchmark

Stanford-Harvard study evaluates 31 systems on 100 real scenarios. LiSA excels in safety, appropriateness, and relevance. AMBOSS invites inquiries via 'NOHARM' comment.

Berlin-based Amboss, which makes study guide apps for medical students and online databases for clinicians, raised €240M, sources say at an €800M+ valuation

Bloomberg: Berlin-based Amboss, which makes study guide apps for medical students and online databases for clinicians, raised €240M, sources say at an €800M+ valuation...

Nixi +++ Amboss +++ Plancraft +++ Langfuse +++ Ravensburger Next Ventures

+++ #StartupTicker +++ Startup of the Week: Nixi +++ Amboss is likely to soon be a Unicorn +++ Definitely note: Plancraft +++ How Langfuse works +++ A playful...

AMBOSS closes €240M financing round and expands its position as the leading co-pilot for physicians worldwide